Attralus AT02-001
Brief description of study
To evaluate the safety and tolerability of IV AT-02 in subjects with systemic amyloidosis. To evaluate the clinical activity of AT-02. Cardiac MRI, NYHA functional classification,and echocardiogram. KCCQ-23, 6MWT
Eligibility of study
You may be eligible for this study if you meet the following criteria:
-
Conditions:
Medical Research
-
Age: - 99 Years
-
Gender: All
TBD
Find a site
,
You have contacted , on
Your message has been sent to the study team at ,
What happens next?
- You can expect the study team to contact you via email or phone in the next few days.
- Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.
You are contacting